Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Prepaid Assets (2019 - 2025)

Revolution Medicines (RVMD) has 7 years of Prepaid Assets data on record, last reported at $49.4 million in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 28.76% year-over-year to $49.4 million; the TTM value through Dec 2025 reached $49.4 million, up 28.76%, while the annual FY2025 figure was $49.4 million, 28.76% up from the prior year.
  • Prepaid Assets reached $49.4 million in Q4 2025 per RVMD's latest filing, up from $46.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $49.4 million in Q4 2025 and bottomed at $6.8 million in Q4 2021.
  • Average Prepaid Assets over 5 years is $21.6 million, with a median of $15.6 million recorded in 2022.
  • Peak YoY movement for Prepaid Assets: plummeted 36.88% in 2023, then surged 237.02% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $6.8 million in 2021, then soared by 55.66% to $10.6 million in 2022, then skyrocketed by 137.22% to $25.1 million in 2023, then soared by 52.89% to $38.3 million in 2024, then rose by 28.76% to $49.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $49.4 million in Q4 2025, $46.0 million in Q3 2025, and $39.3 million in Q2 2025.